Detalles de la búsqueda
1.
Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis.
Int J Mol Sci
; 25(3)2024 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38338977
2.
New insights into pathogenesis point to HIV-1 Tat as a key vaccine target.
Arch Virol
; 166(11): 2955-2974, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34390393
3.
HIV-1 Tat Protein Enters Dysfunctional Endothelial Cells via Integrins and Renders Them Permissive to Virus Replication.
Int J Mol Sci
; 22(1)2020 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-33396807
4.
HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
Retrovirology
; 13(1): 34, 2016 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27277839
5.
HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.
BMC Infect Dis
; 16(1): 442, 2016 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27549342
6.
Association between different anti-Tat antibody isotypes and HIV disease progression: data from an African cohort.
BMC Infect Dis
; 16: 344, 2016 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27450538
7.
HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.
Retrovirology
; 12: 33, 2015 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-25924841
8.
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.
Retrovirology
; 11: 49, 2014 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-24961156
9.
HIV-1 therapeutic vaccines in clinical development to intensify or replace antiretroviral therapy: the promising results of the Tat vaccine.
Expert Rev Vaccines
; 21(9): 1243-1253, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35695268
10.
Impact of viral dose and major histocompatibility complex class IB haplotype on viral outcome in mauritian cynomolgus monkeys vaccinated with Tat upon challenge with simian/human immunodeficiency virus SHIV89.6P.
J Virol
; 84(17): 8953-8, 2010 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-20554774
11.
Contribution of nonneutralizing vaccine-elicited antibody activities to improved protective efficacy in rhesus macaques immunized with Tat/Env compared with multigenic vaccines.
J Immunol
; 182(6): 3718-27, 2009 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19265150
12.
HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
J Immunol
; 182(5): 2888-97, 2009 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19234184
13.
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma.
Nat Med
; 8(3): 225-32, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11875492
14.
Anti-Tat immunity defines CD4+ T-cell dynamics in people living with HIV on long-term cART.
EBioMedicine
; 66: 103306, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839064
15.
NKp44 expression, phylogenesis and function in non-human primate NK cells.
Int Immunol
; 21(3): 245-55, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19147838
16.
The Tat Protein of HIV-1 Prevents the Loss of HSV-Specific Memory Adaptive Responses and Favors the Control of Viral Reactivation.
Vaccines (Basel)
; 8(2)2020 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32512757
17.
HIV therapeutic vaccines aimed at intensifying combination antiretroviral therapy.
Expert Rev Vaccines
; 19(1): 71-84, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31957513
18.
Innovative approaches to develop prophylactic and therapeutic vaccines against HIV/AIDS.
Adv Exp Med Biol
; 655: 189-242, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20047043
19.
Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease.
Vaccines (Basel)
; 7(3)2019 Aug 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31454973
20.
Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.
Front Immunol
; 10: 233, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815001